Take all possible measures to rapidly complete development of priority paediatric drugs and formulations in the pipeline, with the goal of providing the maximum number of new formulations by end of 2018, especially for infants and young children.
Pharmaceutical companies
Sub-Actions & Milestones

Take all possible measures to rapidly complete development of priority paediatric drugs and formulations in the pipeline

Pharmceutical Companies

ViiV will be requesting a meeting with FDA early this summer to review development plans.

-

-

-

-

-

-

-

-

-

Updates

Notes

Responsible